RE:From End SeptemberNice Bunge
It's a simple "laymans" summary of what happened during the messed up 1st dosing and of the potential CR of the 4 withdrawn patients. Very positive. I wsihh Uddin was more vocal as he was the analyst who put the .60-.80 price target. Hoping for much more than that soon!